Core Viewpoint - Jinhai Medical (920925) has announced the internal public notice of the incentive object list for the 2025 restricted stock incentive plan, which has received no objections from employees during the public notice period [1] Group 1: Stock Performance - As of January 19, 2026, Jinhai Medical's stock closed at 24.79 yuan, up 0.08% from the previous trading day, with a total market capitalization of 2.441 billion yuan [1] - The stock opened at 24.92 yuan, reached a high of 24.92 yuan, and a low of 24.66 yuan, with a trading volume of 40.9653 million yuan and a turnover rate of 2.99% [1] Group 2: Incentive Plan Announcement - The company announced that from January 6 to January 16, 2026, it conducted an internal public notice regarding the incentive object list for the 2025 restricted stock incentive plan [1] - The independent directors held a special meeting and concluded that the selected incentive objects meet the relevant legal regulations and the conditions set forth in the draft of the 2025 restricted stock incentive plan, confirming their qualifications [1] - The incentive objects include senior management and core employees of the company and its subsidiaries, excluding independent directors and foreign employees [1]
锦好医疗（920925）披露2025年限制性股票激励计划预留权益授予激励对象名单审查意见及公示情况说明，1月19日股价上涨0.08%